The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Research Funding - AstraZeneca
Patents, Royalties, Other Intellectual Property - HSP90
Phase 1-2 study of progesterone receptor (PR) inhibition with extended-release (ER) onapristone (ONA) alone or in combination with abiraterone (AA) in patients (pts) with castration-resistant prostate cancer (CRPC) incorporating plasma DNA analysis to define androgen receptor (AR) status.
 
Anuradha Jayaram
No Relationships to Disclose
 
Karolina Nowakowska
No Relationships to Disclose
 
Joaquin Mateo
Travel, Accommodations, Expenses - AstraZeneca; Sanofi
 
Sanjeev Kumar
No Relationships to Disclose
 
Tatiana Hernandez
No Relationships to Disclose
 
Ben Fulton
No Relationships to Disclose
 
Daniel Nava Rodrigues
No Relationships to Disclose
 
Ruth Riisnaes
No Relationships to Disclose
 
Alexander Zukiwski
Employment - Arno Therapeutics
Leadership - Arno Therapeutics
Stock and Other Ownership Interests - Arno Therapeutics
 
Alice Susannah Bexon
Consulting or Advisory Role - Arno Therapeutics
 
Stefan Proniuk
Employment - Arno Therapeutics
 
Charles Barranco
Employment - Arno Therapeutics
 
Diletta Bianchini
No Relationships to Disclose
 
Zafeiris Zafeirou
No Relationships to Disclose
 
Raquel Perez Lopez
No Relationships to Disclose
 
Nina Tunariu
No Relationships to Disclose
 
Simon Pacey
No Relationships to Disclose
 
Robert J. Jones
Honoraria - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Ipsen; Janssen; MSD Oncology; Novartis; Pfizer; Roche/Genentech; Sanofi; Seagen
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Exelixis (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; Bayer; Ipsen; Janssen; MSD
 
Johann S. De Bono
Honoraria - Astellas Pharma; AstraZeneca; Genentech/Roche; Pfizer; Sanofi
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Genentech/Roche; Sanofi
Research Funding - AstraZeneca (Inst); Genentech (Inst); Sanofi (Inst)
Patents, Royalties, Other Intellectual Property - Abiraterone Rewards to Inventors (Inst); PARP inhibitors and DNA repair defects (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; AstraZeneca; Genmab; GlaxoSmithKline; Orion; Qiagen; Sanofi; Taiho Pharmaceutical; Vertex
 
Gerhardt Attard
Honoraria - Astellas Pharma; Janssen
Consulting or Advisory Role - Abbott Laboratories; Astellas Pharma; Bayer; ESSA; Janssen-Cilag; Medivation; Millennium; Novartis; Ventana Medical Systems; Veridex
Speakers' Bureau - Astellas Pharma; Janssen; Sanofi; Takeda; Ventana Medical Systems
Research Funding - Arno Therapeutics (Inst); AstraZeneca (Inst); Janssen (Inst)
Patents, Royalties, Other Intellectual Property - I am on The ICR rewards to inventors list of abiraterone acetate.
Travel, Accommodations, Expenses - Abbott Laboratories; Astellas Pharma; Astellas Pharma (I); Bayer; ESSA; Janssen; Janssen (I); Medivation; Ventana Medical Systems
Other Relationship - Institute of Cancer Research